Source:http://linkedlifedata.com/resource/pubmed/id/11811785
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0023516,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205100,
umls-concept:C1332700,
umls-concept:C1332714,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1415900,
umls-concept:C1551336,
umls-concept:C1706438,
umls-concept:C2698600,
umls-concept:C2911684
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-1-28
|
pubmed:abstractText |
Interleukin-12 (IL-12) as well as IL-2 was recently shown to up-regulate CCR5 expression on T-cell receptor (TCR)-triggered human T cells. Because of the functional similarity between interferon-alpha (IFN-alpha) and IL-12, the present study investigated whether IFN-alpha also up-regulates T cell CCR5 expression. CCR5 was marginally detected on T cells from unstimulated human peripheral blood leukocytes (PBLs) and only slightly induced on PBL T cells following stimulation with anti-CD3 plus anti-CD28 monoclonal antibodies (mAbs). When anti-CD3/anti-CD28-triggered PBLs were exposed to IFN-alpha, T cells expressed high levels of CCR5. The levels of CCR5 expression were comparable to those induced by IL-12. However, when purified T cells instead of unfractionated PBL were stimulated with anti-CD3/CD28 and then exposed to IL-12 or IFN-alpha, CCR5 expression was induced by IL-12 but not by IFN-alpha. IFN-alpha was found to act on anti-CD3/anti-CD28-stimulated PBL to promote their IL-12 production. Moreover, addition of anti-IL-12 mAb to IFN-alpha-stimulated cultures of anti-CD3/CD28-pretreated PBL resulted in considerable inhibition of CCR5 expression. Together, these results indicate that IFN-alpha as well as IL-12 up-regulates CCR5 expression on TCR-triggered T cells and that IFN-alpha functions not by acting directly on T cells but via enhancing IL-12 production by PBL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0271-9142
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
402-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11811785-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11811785-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11811785-Cells, Cultured,
pubmed-meshheading:11811785-Humans,
pubmed-meshheading:11811785-Interferon-alpha,
pubmed-meshheading:11811785-Interleukin-12,
pubmed-meshheading:11811785-Receptors, Antigen, T-Cell,
pubmed-meshheading:11811785-Receptors, CCR5,
pubmed-meshheading:11811785-Up-Regulation
|
pubmed:year |
2001
|
pubmed:articleTitle |
IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells.
|
pubmed:affiliation |
Department of Oncology, Biomedical Research Center, Osaka University Graduate School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|